Mira Pharmaceuticals Appoints BDO USA as New Auditor
Ticker: MIRA · Form: 8-K · Filed: Dec 20, 2024 · CIK: 1904286
| Field | Detail |
|---|---|
| Company | Mira Pharmaceuticals, Inc. (MIRA) |
| Form Type | 8-K |
| Filed Date | Dec 20, 2024 |
| Risk Level | medium |
| Pages | 3 |
| Reading Time | 4 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: auditor-change, accounting
TL;DR
Mira Pharma ditches old auditor for BDO USA, effective Dec 16.
AI Summary
Mira Pharmaceuticals, Inc. announced on December 16, 2024, that it has appointed BDO USA, P.A. as its new independent registered public accounting firm. This change follows the resignation of its previous auditor, Weinberg & Company, P.A., effective December 12, 2024. The company's board of directors, with the recommendation of the audit committee, approved this change.
Why It Matters
Changing auditors can signal a shift in financial oversight or address concerns about previous audits, potentially impacting investor confidence and future financial reporting.
Risk Assessment
Risk Level: medium — A change in auditor, especially if not due to standard rotation, can sometimes indicate underlying financial or accounting issues.
Key Players & Entities
- Mira Pharmaceuticals, Inc. (company) — Registrant
- BDO USA, P.A. (company) — New independent registered public accounting firm
- Weinberg & Company, P.A. (company) — Former independent registered public accounting firm
- December 16, 2024 (date) — Effective date of auditor change
- December 12, 2024 (date) — Effective date of former auditor's resignation
FAQ
When did Mira Pharmaceuticals, Inc. appoint BDO USA, P.A. as its new independent registered public accounting firm?
Mira Pharmaceuticals, Inc. appointed BDO USA, P.A. as its new independent registered public accounting firm on December 16, 2024.
Who was Mira Pharmaceuticals, Inc.'s previous independent registered public accounting firm?
Mira Pharmaceuticals, Inc.'s previous independent registered public accounting firm was Weinberg & Company, P.A.
When did Weinberg & Company, P.A. resign as Mira Pharmaceuticals, Inc.'s auditor?
Weinberg & Company, P.A. resigned as Mira Pharmaceuticals, Inc.'s auditor effective December 12, 2024.
Did the audit committee recommend the change in auditors?
Yes, the company's board of directors, with the recommendation of the audit committee, approved the change in independent registered public accounting firm.
Were there any disagreements with Weinberg & Company, P.A. that led to their resignation?
The filing does not state any disagreements with Weinberg & Company, P.A. that led to their resignation.
Filing Stats: 899 words · 4 min read · ~3 pages · Grade level 15.2 · Accepted 2024-12-20 17:00:32
Key Financial Figures
- $0.0001 — nge on which registered Common Stock, $0.0001 par value per share MIRA The Nasdaq
Filing Documents
- form8-k.htm (8-K) — 45KB
- ex16-1.htm (EX-16.1) — 6KB
- ex16-1_001.jpg (GRAPHIC) — 17KB
- 0001493152-24-051091.txt ( ) — 251KB
- mira-20241216.xsd (EX-101.SCH) — 3KB
- mira-20241216_lab.xml (EX-101.LAB) — 33KB
- mira-20241216_pre.xml (EX-101.PRE) — 24KB
- form8-k_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MIRA PHARMACEUTICALS, INC. Dated: December 20, 2024 By: /s/ Erez Aminov Name: Erez Aminov Title: Chief Executive Officer